ArticleThe American journal of pathology2011

In vivo and in vitro evidence that PPARγ ligands are antagonists of leptin signaling in breast cancer.

Stefania Catalano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.